Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease

BACKGROUND: Pediatric patients with advanced chronic kidney disease (CKD) are often prescribed oral phosphate binders (PBs) for the management of hyperphosphatemia. However, available PBs have limitations, including unfavorable tolerability and safety. METHODS: This phase 3, multicenter, randomized,...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenbaum, Larry A., Jeck, Nikola, Klaus, Günter, Fila, Marc, Stoica, Cristina, Fathallah-Shaykh, Sahar, Paredes, Ana, Wickman, Larysa, Nelson, Raoul, Swinford, Rita D., Abitbol, Carolyn Larkins, Balgradean, Mihaela, Jankauskiene, Augustina, Perrin, Amandine, Enoiu, Milica, Ahn, Sun-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009783/
https://www.ncbi.nlm.nih.gov/pubmed/33106892
http://dx.doi.org/10.1007/s00467-020-04805-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009783/
https://www.ncbi.nlm.nih.gov/pubmed/33106892
http://dx.doi.org/10.1007/s00467-020-04805-y

Ejemplares similares